Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 18, 2026

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
07:03

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Published on: March 18, 2019

Cell-based approaches for cardiac repair.

Michael Rubart1, Loren J Field

  • 1Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, 1044 West Walnut Street, RM W376, Indianapolis, IN 46202, USA.

Annals of the New York Academy of Sciences
|November 30, 2006
PubMed
Summary

Cardiovascular disease causes heart cell loss, diminishing function. This review explores new therapies like cell therapy and cell cycle activation to regenerate heart muscle cells and restore cardiac function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enrichment of mutant calmodulin protein in a murine model of a human calmodulinopathy.

JCI insight·2025
Same author

Antiarrhythmic effects of mirabegron on ventricular fibrillation in Langendorff-perfused rabbit ventricles.

The Journal of physiology·2025
Same author

K<sup>+</sup> currents in ventricular cardiomyocytes of p.N98S-calmodulin mutant mice.

American journal of physiology. Heart and circulatory physiology·2024
Same author

Insulin mitigates acute ischemia-induced atrial fibrillation and sinoatrial node dysfunction ex vivo.

JCI insight·2024
Same author

Antisense Oligonucleotide Therapy for Calmodulinopathy.

Circulation·2024
Same author

Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice.

Circulation research·2024

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Cardiac Physiology

Background:

  • Cardiovascular diseases frequently lead to cardiomyocyte (heart muscle cell) loss through necrosis and apoptosis.
  • The progressive depletion of contractile cells impairs overall cardiac function.
  • Current research focuses on strategies to prevent cell death or regenerate lost cardiomyocytes.

Purpose of the Study:

  • To review and discuss the current state of interventions aimed at repopulating the heart with new, functional cardiomyocytes.
  • To evaluate the potential of various cell-based and cell cycle activation therapies for cardiac repair.

Main Methods:

  • Literature review of existing research on cardiomyocyte loss and regeneration strategies.
  • Analysis of cell therapy approaches, including cardiomyocyte cell therapy and myogenic stem cell therapy.

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

Related Experiment Videos

Last Updated: Jul 18, 2026

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
07:03

Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model

Published on: March 18, 2019

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

  • Examination of cell cycle activation therapy as a method for endogenous cardiomyocyte proliferation.

    • Main Results:

    • Multiple therapeutic avenues are being explored to address cardiomyocyte loss in cardiovascular disease.
    • Strategies focus on either reducing cell death or replacing lost cells with newly generated cardiomyocytes.
    • The integration of de novo cardiomyocytes into the existing cardiac syncytium is a key challenge.

    Conclusions:

    • Regenerating functional cardiomyocytes is crucial for improving cardiac function after injury.
    • Cell therapy and cell cycle activation represent promising, yet challenging, approaches.
    • Further research is needed to ensure the successful integration and long-term function of regenerated cardiomyocytes.